MAPT and Alzheimer disease: The hypothesis that Aβ-NP, tau-NFT, as well as Aβ or tau oligomers, are the only responsible factors for the cognitive declining in AD has not been satisfactorily confirmed by a series of neuropathologic, neuroimaging, and biochemical studies attempting to establish linear correlations between AD pathology and cognitive decline [6-12].